by John Conrad | Oct 21, 2024 | iBIO News
Bristol Myers Squibb-sponsored kits will be distributed to 4th-8th graders at Frank W. Gunsaulus Scholastic Academy CHICAGO, IL – October 21, 2024 – The Illinois Biotechnology Innovation Organization (iBIO) is partnering with Bristol Myers Squibb (BMS) to...
by John Conrad | Oct 16, 2024 | iBIO News
In the heart of the Midwest, a technological revolution is brewing that could transform the landscape of pharmaceutical research. Chicago, long known for its towering skyscrapers and deep-dish pizza, is now poised to become the epicenter of a quantum-powered...
by John Conrad | Oct 10, 2024 | Member News
Vanqua Bio has announced positive interim results from its Phase 1 clinical trial of VQ-101, a novel drug designed to treat GBA-Parkinson’s and related disorders. This breakthrough could potentially slow or even halt the progression of Parkinson’s disease,...
by John Conrad | Oct 8, 2024 | Member News
Astellas Pharma Inc. and AviadoBio Ltd. have announced an exclusive option and license agreement for AVB-101, a promising gene therapy currently in Phase 1/2 clinical trials. This collaboration marks a significant step forward in addressing the urgent need for...
by John Conrad | Oct 4, 2024 | Uncategorized
Chicago-based biotech company receives FDA recognition for innovative spinal implant In a significant development for the field of regenerative medicine, Amphix Bio announced on October 3, 2024, that it has received Breakthrough Device designation from the U.S. Food...
